Scholarlink

Background <p>Recent multicenter studies suggest a temporal trend of a decreasing number of patients with classic early-onset mesial temporal lobe epilepsy (mTLE) with ammon’s horn sclerosis (mTLE–AHS). In parallel, the awareness of late-onset mTLE patients with suspected limbic encephalitis (sLE) is increasing. To evaluate a potential epidemiological shift, a large cohort of mTLE patients collected over 4 decades was analyzed.</p> Methods <p>Anonymized data sets of a monocentric cohort of 1,556 patients with the diagnosis of mTLE, who underwent their very first neuropsychological assessment between 1986 and 2024 in the Department of Epileptology at the University Hospital Bonn in Germany, were retrospectively evaluated in regard to temporal trends of age, age at epilepsy onset, neuropsychological performance, and MRI pathology. Five-year intervals were evaluated.</p> Results <p>Most significant was a trend of an increasing age at epilepsy onset over time (from 12 to 36 years), education and IQ increased over time, impairments became less global, and verbal/figural memory impairments became less marked and discriminative over time. While the number of patients with mTLE remained quite stable since 1996 (50–60% of all TLE patients seen), patients with early-onset mTLE–AHS (<i>n</i> = 1079, average age at&#xa0;epilepsy onset: 16&#xa0;years) faded over time (from 100 to 32%), while the patients with late-onset mTLE suspicious of limbic encephalitis (<i>N</i> = 477, average age at&#xa0;epilepsy onset: 40&#xa0;years) became increasingly prevalent (from 0 to 68%).</p> Conclusions <p>Trends of changing etiologies as well as altering clinical and neuropsychological features of patients with mTLE suggest an epidemiological shift over the past decades. Overlapping distributions of fading early-onset classic mTLE–AHS and an increasing influx of late-onset sLE fit the clinical observations and demand retrospective follow-up studies in other countries/regions to disentangle triggering factors. Prospective studies should investigate temporal trends in autoantibody subgroups of patients with sLE.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Temporal trends indicate an epidemiological shift in the pathology of mesial temporal lobe epilepsy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月24日

查看全文
  • Christoph Helmstaedter,
  • Sarah Al-Haj Mustafa,
  • Juri-Alexander Witt

摘要

Background

Recent multicenter studies suggest a temporal trend of a decreasing number of patients with classic early-onset mesial temporal lobe epilepsy (mTLE) with ammon’s horn sclerosis (mTLE–AHS). In parallel, the awareness of late-onset mTLE patients with suspected limbic encephalitis (sLE) is increasing. To evaluate a potential epidemiological shift, a large cohort of mTLE patients collected over 4 decades was analyzed.

Methods

Anonymized data sets of a monocentric cohort of 1,556 patients with the diagnosis of mTLE, who underwent their very first neuropsychological assessment between 1986 and 2024 in the Department of Epileptology at the University Hospital Bonn in Germany, were retrospectively evaluated in regard to temporal trends of age, age at epilepsy onset, neuropsychological performance, and MRI pathology. Five-year intervals were evaluated.

Results

Most significant was a trend of an increasing age at epilepsy onset over time (from 12 to 36 years), education and IQ increased over time, impairments became less global, and verbal/figural memory impairments became less marked and discriminative over time. While the number of patients with mTLE remained quite stable since 1996 (50–60% of all TLE patients seen), patients with early-onset mTLE–AHS (n = 1079, average age at epilepsy onset: 16 years) faded over time (from 100 to 32%), while the patients with late-onset mTLE suspicious of limbic encephalitis (N = 477, average age at epilepsy onset: 40 years) became increasingly prevalent (from 0 to 68%).

Conclusions

Trends of changing etiologies as well as altering clinical and neuropsychological features of patients with mTLE suggest an epidemiological shift over the past decades. Overlapping distributions of fading early-onset classic mTLE–AHS and an increasing influx of late-onset sLE fit the clinical observations and demand retrospective follow-up studies in other countries/regions to disentangle triggering factors. Prospective studies should investigate temporal trends in autoantibody subgroups of patients with sLE.